GLOBUS MEDICAL INC

GMEDNYSE • USD
72.14 USD
↘ 0.16 (0.22%)AT CLOSE (03:59 PM EST)
72.15
↗ 0.01 (0.01%)
POST MARKET (AS OF 07:45 PM EST)
Post Market
AS OF 07:45 PM EST
72.15
↗ 0.01 (0.01%)
🔴Market: CLOSED

Shares of GLOBUS MEDICAL INC (GMED) are trading at $72.14. The stock presents a mixed profile: our models indicate a Buy for underlying fundamentals, while technical indicators flash a Strong Sell. Notable factors include a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$72.75
High?$73.45
Low?$71.72
Prev. Close?$72.30
Volume?1.5M
Avg. Volume?1.9M
VWAP?$72.19
Rel. Volume?0.83x
Bid / Ask
Bid?$70.00 × 100
Ask?$74.66 × 100
Spread?$4.66
Midpoint?$72.33
Valuation & Ratios
Market Cap?9.6B
Shares Out?134.3M
Float?131.1M
Float %?97.6%
P/E Ratio?17.16
P/B Ratio?2.00
EPS?$4.20
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Through innovative technology and M&A activity, Globus Medical transformed into the number two medical device manufacturer in the competitive spine market. The firm was founded in 2003 with a heavy focus on internal research and development but vaulted its market share in 2023 through a merger with former competitor NuVasive. In 2025, the company acquired Nevro, a smaller player that specialized in spinal cord stimulation therapy. Globus Medical reports two business segments, musculoskeletal solutions and enabling technologies, which consist of implants used in surgery and associated technologies that assist the physician.
Employees
6.0K
Market Cap
9.6B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2012-08-03
Address
2560 GENERAL ARMISTEAD AVENUE
AUDUBON, PA 19403
Phone: 610-930-1800
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
100
Momentum?
71
Short Sent.?
44
Piotroski F-Score?5/9Mixed
Altman Z-Score?9.56Safe
Confidence?64%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.21%Elevated
Short Interest?9.5M
Days to Cover?8.1
Free Float131.1M
Avg Daily Volume1.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.88Strong
Quick Ratio?2.41Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 3 peers + S&P 500
Score
94/100
P/E?
Peers
75
S&P
74
17.2CHEAP▾
P/B?
Peers
75
S&P
74
2.00CHEAP▾
P/S?
Peers
100
S&P
50
3.05FAIR▾
P/FCF?
Peers
75
S&P
82
12.5CHEAP▾
EV/EBITDA?
Peers
100
S&P
85
9.2CHEAP▾
EV/Sales?
Peers
100
S&P
62
2.91CHEAP▾
Returns & Efficiency
ROE?
Peers
75
S&P
41
11.6%FAIR▾
ROA?
Peers
75
S&P
75
10.1%STRONG▾
Cash Flow & Enterprise
FCF?$766.5M
Enterprise Value?$9.1B
Fundamentals ratios updated end of day